Science Current Events | Science News | Brightsurf.com
 

Gene therapy against brain cancer

May 16, 2016

Only a few days ago, the press (especially in English-speaking countries) enthusiastically announced the publication of a study that described in great detail the genetics of breast cancer, a discovery that according to many marks a breakthrough in the battle against this cancer. This kind of news confirms the impression that in the near future the war against cancer will be fought on the battlefields of genetics. Italy too, is working on this front. At SISSA, for example, where Antonello Mallamaci and his group have just published highly promising results on the application of gene therapy against glioblastomas, a family of brain tumours among the most common and aggressive. A diagnosis of glioblastoma is literally equal to a very imminent death sentence: "surgery is rarely curative, as these tumours insinuate themselves in healthy tissues, and also chemo- and radiotherapy have little effectiveness. In a short while, very aggressive recurrences develop and that marks the end" explains Antonello Mallamaci, SISSA professor who also collaborates with the Telethon Foundation. "Our approach is radically different: we introduce an additional copy of a given gene into the tumour cells so as to impair their reproductive capacity and lead them to suicide".

The idea for this study came to Mallamaci - who is not an oncologist - after years of close investigation of a particular gene called Emx2. One of the characteristics of this gene, explains the scientist, is to inhibit proliferation of astrocytes during embryonic growth. Glial cells, including astrocytes, are part of the nervous system, where they nourish and protect neurons and finely regulate their function.

"We know that during the early stages of development of the nervous system only neurons grow, whereas glial cells only start to proliferate when neuronal growth is practically complete", explains Carmen Falcone, SISSA research scientist and first author of the paper. "In our previous studies we discovered that Emx2 is expressed at very high levels during the neuronal generation phase, whereas its action declines dramatically when the glial cells start to grow. So the gene keeps astrocyte growth in check up to a certain point".

If it can block astrocytes, why not try and use it to block glioblastomas? "These tumours share many features with astroglia" comments Mallamaci, "hence the idea to use them to our advantage. With the contribution of IST in Genoa, which supplied us with cultures of various types of glioblastoma, we started doing some in vitro tests". And these tests went "beyond our rosiest expectations", explain Falcone and Mallamaci: "in nearly all of the samples, the tumour tissue literally collapsed in less than a week.".

At this point the study continued in two directions. The team first modelled in vitro the molecular mechanisms intervening between when the therapeutic gene is "switched on" and the final effect, finding that the gene attacks tumour metabolism at no less than six points, a result defined as "very robust" by the researchers.

A Trojan horse inside the tumour

After the in vitro studies, the group started its first in vivo experiments on mice, adopting all due precautions to prevent unacceptable suffering of the animals. "So, to prevent damage to the healthy cells, neurons and astrocytes, we selected a specific 'promotor', a piece of DNA that causes the therapeutic gene to become activated only in tumour cells, without attacking the other cells, and we replicated the same result as seen in the first in vitro tests".

Gene therapy is based on the insertion of ad hoc genes into a host cell's genome so that these genes can function inside the cell by borrowing its genetic machinery. How is a bit of genetic code added to a living cell? Scientists use the mechanisms naturally adopted by viruses. Viruses are strange entities: although they have their own genome, they are not able to duplicate, and reproduce, by themselves. For this reason they sneak into cells, and insert their own DNA into the host genome, so that the cell starts working for them by duplicating their genes as well and forming other viruses. "By making the virus harmless, that is, by emptying the shell containing its genome and filling it with therapeutic genes, we can add new genes, or enhanced versions of endogenous genes, to the host cell", explains Falcone.

So that is precisely what Mallamaci and colleagues did: they introduced a particularly active version of Emx2 into the tumour cells. The results so far have been unequivocal and have demonstrated that Emx2 is able to kill the cells of at least four different types of glioblastoma, both in vitro and in vivo in rodents, without damaging the healthy cells of nervous system. Since they also observed that the treatment targeted may points of the tumour process, there are good chances of effectively contrasting the development of aggressive recurrences. "For these to form, there has to be a process of selection of the strongest tumour cells. By targeting them at a variety of different points, we raise the standards in this selection process and - hopefully - we prevent the recurrences", concludes Mallamaci. "Now we plan to extend the in vivo tests to other glioblastomas. With a lot of hard work and a bit of luck we hope that in a few years' time all this can translate into a tangible benefit for the unfortunate patients afflicted by this disease".

International School of Advanced Studies (SISSA)


Related Gene Therapy Current Events and Gene Therapy News Articles


Restoring chemotherapy sensitivity by boosting microRNA levels
By increasing the level of a specific microRNA (miRNA) molecule, researchers have for the first time restored chemotherapy sensitivity in vitro to a line of human pancreatic cancer cells that had developed resistance to a common treatment drug.

Long-term survival achieved in metastatic melanoma with personalized vaccine
Two patients with melanoma that had spread to the liver survived for at least 8.5 and 12 years after resection of the hepatic tumor and treatment with patient-specific immunotherapeutic vaccines.

Junction opening protein boosts cancer-killing effect of oncolytic virus
A new study shows that the anti-tumor effect of oncolytic virus therapy is significantly greater in mice when the virus is genetically modified to express a junction opening (JO) protein, which helps the cancer-killing agent better penetrate solid tumors.

Research findings reveal potential to reverse cancer-related nerve pain
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.

Progress and promise of gene transfer and gene editing to cure beta-thalassemias
Promising results from the first clinical trials of globin gene transfer to treat beta-thalassemias-inherited forms of anemia-have eliminated the need for blood transfusions in some individuals.

New research from Yale and MIT describes bioreactor to support whole lung regeneration
An innovative mechanical system that mimics the ventilation and blood flow in the chest cavity, housed in a specialized, sterile bioreactor, can support the growth of engineered whole lungs at human scale.

Gene therapy halts pulmonary hypertension progression in large animal pre-clinical study
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.

Promising results reported in study of AAV-based gene delivery to treat methylmalonic acidemia
A new study in patients with the inherited metabolic disorder methylmalonic academia (MMA) found lower than expected levels of antibodies against the adeno-associated viral (AAV) vectors being developed for gene therapy to replace the enzyme (MUT) that is deficient in MMA.

What can Frizzled7 reveal about breast cancer development?
A new study shows that Frizzled7 (FZD7), a protein present on human breast epithelial cells and a component of the Wnt signaling pathway is uniquely controlled by the Notch signaling pathway, both of which play key roles in mammary gland formation and breast cancer development.

Induced pluripotent stem cells (iPSC) shown to form multiple types of functional lymphocytes in vivo
A new study demonstrates that iPSC have the potential to differentiate into multiple lineages of functional lymphocytes, including CD4+ T cells, B cells, and natural killer cells, without bias.
More Gene Therapy Current Events and Gene Therapy News Articles

The Gene Therapy Plan: Taking Control of Your Genetic Destiny with Diet and Lifestyle

The Gene Therapy Plan: Taking Control of Your Genetic Destiny with Diet and Lifestyle
by Mitchell L. Gaynor MD (Author), Mehmet C. Oz M.D. (Foreword)


Your genes are not your destiny: learn to prevent disease, improve brain function, and reverse the course of obesity and premature aging through easy-to-adopt nutrition and lifestyle changes that target your DNA
 
While we cannot alter the genes we are born with, we can prevent and reverse disease with foods, supplements, and lifestyle choices that turn good genes on and bad genes off. In his pathbreaking plan, Dr. Mitchell Gaynor—a renowned oncologist and pioneer in integrative medicine—focuses on obesity, heart disease, diabetes, cancer, and aging to explain what we can do to keep our bodies on their natural paths toward healthy, balanced functioning.
 
The Gene Therapy Plan presents practical, evidence-based approaches to diet, including juices, recipes, and...

Gene therapy

Gene therapy
by The Open University


This 4-hour free course looked at gene correction and the use of genes to treat disorders. Somatic and germline gene therapy were also discussed.

The Forever Fix: Gene Therapy and the Boy Who Saved It

The Forever Fix: Gene Therapy and the Boy Who Saved It
by Ricki Lewis (Author)


Fascinating narrative science that explores the next frontier in medicine and genetics through the very personal prism of the children and families gene therapy has touched.Eight-year-old Corey Haas was nearly blind from a hereditary disorder when his sight was restored through a delicate procedure that made medical history. Like something from a science fiction novel, doctors carefully introduced viruses bearing healing genes into Corey's eyes―a few days later, Corey could see, his sight restored by gene therapy.
THE FOREVER FIX is the first book to tell the fascinating story of gene therapy: how it works, the science behind it, how patients (mostly children) have been helped and harmed, and how scientists learned from each trial to get one step closer to its immense promise, the...

The Gene: An Intimate History

The Gene: An Intimate History
by Siddhartha Mukherjee (Author)


THE #1 NEW YORK TIMES BESTSELLER
A New York Times Notable Book
A Washington Post and Seattle Times Best Book of the Year

From the Pulitzer Prize-winning author of The Emperor of All Maladies—a fascinating history of the gene and “a magisterial account of how human minds have laboriously, ingeniously picked apart what makes us tick” (Elle).

“Dr. Siddhartha Mukherjee dazzled readers with his Pulitzer Prize-winning The Emperor of All Maladies in 2010. That achievement was evidently just a warm-up for his virtuoso performance in The Gene: An Intimate History, in which he braids science, history, and memoir into an epic with all the range and biblical thunder of Paradise Lost” (The New York Times). In this biography Mukherjee brings to life the quest to...

Translating Gene Therapy to the Clinic: Techniques and Approaches

Translating Gene Therapy to the Clinic: Techniques and Approaches
by Jeffrey Laurence (Editor), Michael Franklin (Editor)


Translating Gene Therapy to the Clinic, edited by Dr. Jeffrey Laurence and Michael Franklin, follows the recent, much-lauded special issue of Translational Research in emphasizing clinical milestones and critical barriers to further progress in the clinic. This comprehensive text provides a background for understanding the techniques involved in human gene therapy trials, and expands upon the disease-specific situations in which these new approaches currently have the greatest therapeutic application or potential, and those areas most in need of future research. It emphasizes methods, tools, and experimental approaches used by leaders in the field of translational gene therapy. The book promotes cross-disciplinary communication between the sub-specialties of medicine, and remains unified...

Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology: Principles, Delivery and Pharmacological and Biomedical Applications of ... (Icp Textbooks in Biomolecular Sciences)

Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology: Principles, Delivery and Pharmacological and Biomedical Applications of ... (Icp Textbooks in Biomolecular Sciences)
by Daniel Scherman (Author), Daniel Scherman (Editor)


This unique advanced textbook provides a clear and comprehensive description of the field of gene delivery, gene therapy and genetic pharmacology, with descriptions of the main gene transfer vectors and a set of selected therapeutic applications, along with safety considerations. The use of gene transfer is exponential in the scientific and medical community, both for cell biology experiments and for gene therapy revolutionary strategies. The advanced textbook should thus be of invaluable utility to Master, PhD or MD students, post-doctoral scientists or medical doctors, and to any scientist using gene transfer techniques or implementing gene therapy strategies. It provides the necessary background material needed to further explore the subject and relevant research literature. More...

Scientific American: Gene Therapy’s Second Act

Scientific American: Gene Therapy’s Second Act
by Scientific American


Ricki Lewis, a science writer with a Ph.D. in genetics, reports on how after a decade and a half of tragic setbacks scientists now believe that gene therapy is ready to enter the clinic.This article was published in the March 2014 edition of Scientific American.

Gene Therapy

Gene Therapy
by Mauro Giacca (Author)


I entered the gene therapy field in the mid-1990s, being fascinated by the immense potential of genes as drugs for the treatment of human disease. Since then, I have experienced the ups and downs of this discipline, and tried to contribute with my work and that of my laboratory to the development of innovative approaches to the treatment of cardiovascular disorders. During these years, I have had several opp- tunities to speak on gene therapy at lectures and academic lessons, and have often noticed that the field is very attractive to scientists of all disciplines. However, as yet no comprehensive book on the subject has been published. Indeed, most books in the field are either a collection of gene transfer laboratory protocols or deal with the subject in a rather superficial manner....

Gene Therapy for Neurological Disorders: Methods and Protocols (Methods in Molecular Biology)

Gene Therapy for Neurological Disorders: Methods and Protocols (Methods in Molecular Biology)
by Fredric P. Manfredsson (Editor)


This volume provides a clear and detailed roadmap of how to design and execute a gene therapy experiment in order to obtain consistent results. Chapters in this book disseminate bits of unknown information that are important to consider during the course of experimentation and will answer questions such as: What delivery vehicle do you use?; How will you ensure that your vector retains stability?; What expression system best fits your needs?; What route will you choose to deliver your gene therapy agent?; How will you model the neurodegenerative disorder that you aim to investigate and what are the proven methods to treat these disorders in preclinical models? Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective...

Gene Therapy

Gene Therapy
by Mary Colavito (Author), Michael A. Palladino (Author)


KEY MESSSAGE: Will gene therapy one day become the ultimate application of genetic technology?  Gene Therapy, the newest booklet in the Special Topics in Biology Series, addresses this question by exploring gene therapy as a complex technology for delivering therapeutic genes as a way to treat and cure human genetic diseases. Author Mary Colavito provides an overview of the basic science involved in gene therapy methods and chronicles the history of gene therapy by discussing successful and ongoing gene therapy treatments as well as adverse outcomes in some cases of gene therapy. Also discussed are challenges that must be overcome for gene therapy to become a more reliable and readily accessible approach for treating a multitude of genetic diseases that affect humans. Gene Therapy:...

© 2017 BrightSurf.com